No­var­tis fails to win ap­peal in whistle­blow­er case in­volv­ing can­cer drug study

A state rul­ing was hand­ed down to No­var­tis on Mon­day, and not in the Big Phar­ma’s fa­vor.

The rul­ing from New Jer­sey’s Su­pe­ri­or Court, Ap­pel­late Di­vi­sion from ear­li­er this week up­held a tri­al court’s rul­ing against No­var­tis from 2019 that man­dat­ed that a for­mer com­pa­ny ex­ec-turned whistle­blow­er be paid a net amount of ap­prox­i­mate­ly $1.5 mil­lion.

The ap­peal, heard by a 3-judge pan­el, was ar­gued be­fore the court on Feb­ru­ary 3rd as both par­ties ap­pealed cer­tain el­e­ments and judge­ments in the case.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER